|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2006-1-2
|
|
pubmed:abstractText |
We reviewed our prospectively maintained database of 2005 liver transplantations. Therapy was either started de novo or converted from calcineurin inhibitors (CNIs) to sirolimus as the main immunosuppressive agent for nephrotoxicity or rejection. Glomerular filtration rate (GFR) was determined with iodine 125-labeled sodium isthalamate (Glofil-125), and serum creatinine concentration was obtained before and 3 months after transplantation, and yearly in both groups. Sirolimus levels were 10 to 15 ng/mL in patients at less than 3 months after transplantations and 5 to 10 ng/mL in the remaining patients. All patients received mycophenolate mofetil as maintenance therapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
pubmed-author:ChinnakotlaSS,
pubmed-author:DawsonSS3rd,
pubmed-author:GoldsteinR MRM,
pubmed-author:IkegamiTT,
pubmed-author:KlintmaimG BGB,
pubmed-author:KlintmalmG BGB,
pubmed-author:LevyM FMF,
pubmed-author:MartinA PAP,
pubmed-author:NarasimhanGG,
pubmed-author:RandallH BHB,
pubmed-author:SanchezE QEQ,
pubmed-author:SaracinoGG,
pubmed-author:UemuraTT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4416-23
|
|
pubmed:dateRevised |
2006-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:16387135-Creatinine,
pubmed-meshheading:16387135-Drug Therapy, Combination,
pubmed-meshheading:16387135-Follow-Up Studies,
pubmed-meshheading:16387135-Glomerular Filtration Rate,
pubmed-meshheading:16387135-Graft Survival,
pubmed-meshheading:16387135-Humans,
pubmed-meshheading:16387135-Immunosuppressive Agents,
pubmed-meshheading:16387135-Kidney Function Tests,
pubmed-meshheading:16387135-Liver Diseases,
pubmed-meshheading:16387135-Liver Transplantation,
pubmed-meshheading:16387135-Retrospective Studies,
pubmed-meshheading:16387135-Sirolimus,
pubmed-meshheading:16387135-Time Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years.
|
|
pubmed:affiliation |
Transplantation Services, Baylor University Medical Center, Dallas, Texas 75246, USA. edmunds@baylorhealth.edu
|
|
pubmed:publicationType |
Journal Article
|
